Form 4: Clene Director Matlin Receives Stock Option Grant
Insider Stock Option Grant
Clene Inc. Director David J. Matlin was granted 3,692 stock options under the company's 2020 Stock Plan, vesting immediately.
Summary
- David J. Matlin, a Director and 10% Owner of Clene Inc. (CLNN), was granted stock options.
- The transaction occurred on November 13, 2025.
- The grant was for 3,692 shares of Common Stock.
- The exercise price for these options is $7.30 per share.
- The options were granted under the Clene Inc. Amended 2020 Stock Plan.
- These options vest immediately upon grant.
- The expiration date for these options is November 12, 2035.
Sentiment
Score: 6
Explanation: The grant of stock options to a director is a routine compensation event that aligns management interests with shareholders. It is mildly positive due to this alignment but does not indicate significant operational or financial news.
Positives
- The grant of stock options to a Director and 10% Owner, David J. Matlin, aligns his interests with those of other shareholders.
- Immediate vesting of the options provides the director with immediate equity exposure and incentive.
Negatives
- The grant of new options could lead to minor future dilution if exercised, though the amount (3,692 shares) is relatively small.
Risks
- The value of the stock options is subject to the future market price of Clene Inc.'s common stock. If the stock price does not exceed the exercise price of $7.30 per share, the options may expire worthless.
- Market volatility and general economic conditions could negatively impact the company's stock price, affecting the potential value of the options.
Future Outlook
N/A. This filing is a report of an insider transaction and does not contain forward-looking statements or guidance regarding the company's future performance.
Management Comments
- N/A. This Form 4 filing does not include direct quotes or paraphrased statements from company management.
Industry Context
N/A. This filing reports an individual insider transaction and does not provide information relevant to broader industry trends or competitive analysis.
Comparison to Industry Standards
- N/A. This filing is a report of an individual insider compensation event and does not contain information suitable for comparison to global benchmarks or specific comparable companies/projects.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Plan Utilization | Stock options were granted under the Clene Inc. Amended 2020 Stock Plan, indicating the ongoing use of the plan for director compensation. | 11/13/2025 | Reinforces the company's existing equity compensation framework for aligning director incentives with shareholder value. |
Stakeholder Impact
- Shareholders: Minor potential for future dilution if options are exercised, but also increased alignment of a significant owner's interests with shareholder value.
- Director (David J. Matlin): Receives equity incentive, aligning personal financial interests with the company's stock performance.
Next Steps
- N/A. This filing reports a completed transaction and does not outline future actions, events, or milestones.
Key Dates
| Date | Description |
|---|---|
| 11/13/2025 | Date of stock option grant to David J. Matlin. |
| 11/12/2035 | Expiration date of the granted stock options. |
Keywords
Clene Inc., CLNN, Stock Option Grant, Form 4, Insider Transaction, Director Compensation, Equity Incentive, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.